Home - Pulmocare

Mail Us

info@pulmocareindia.com

Call Us

0141-3542859

Pulmocare Your Partner in Safer Care

Redefining Healthcare Safety with Innovative Infection Control Solutions

ABOUT US

Redefining Healthcare Safety with Innovative Infection Control Solutions

At Pulmocare Medical Systems Pvt Ltd, we champion healthcare safety through innovative infection control solutions. Founded in 2018, our journey began with a collective vision to combat Hospital Acquired Infections (HAIs) that pose a serious threat to patient well-being worldwide. With a rich background in Health Care Products and Services, coupled with extensive collaborations with renowned international brands in Critical Care, Respiratory, and Anesthesiology, our founding team has been at the forefront of revolutionizing healthcare safety.

Mission

Preventing infections, empowering safer healthcare.

Vision

Creating a world free from Hospital Acquired Infections, ensuring safety for all.

ISO Certified - 9001:2015 & 13485:2016

HAIs

Global Impact of Hospital Acquired Infections (HAIs)

Hospital Acquired Infections (HAIs) pose a global health crisis, affecting millions annually. India reports 170,574 cases, causing 7,583 deaths among 1.43 billion people. In the United States, 1.7 million infections lead to 99,000 fatalities within a population of 340.83 million. Canada sees 220,000 cases, resulting in 8,000 deaths among 38.78 million individuals. HAIs present challenges due to antibiotic resistance and inadequate control measures. Pulmocare recognizes this urgency, aiming to pioneer innovative solutions. Our mission targets infection prevention, striving for a world where safer healthcare practices eliminate the significant impact and fatalities caused by Hospital Acquired Infections.

Empowering Healthcare Safety

Innovative Solutions to Control HAIs

Pulmocare pioneers innovative products and services tailored to combat HAIs effectively, particularly in ICU environments. Our solutions integrate cutting-edge technology with a deep understanding of healthcare settings, ensuring unparalleled effectiveness in infection prevention. From air purification systems to advanced infection control devices, each solution is engineered to foster a safer and healthier healthcare ecosystem.

Ready to explore our innovative solutions transforming healthcare safety?

Know how Pulmocare’s advanced technology is reshaping infection control in critical care settings.

Explore Our Products

Innovative Solutions to eliminate HAIS

Advanced Infection Control Solutions

Our UV-based Occissor and IAPS systems reduce Hospital Acquired Infections (HAIs), ensuring superior sterilization in critical care settings.

Expertise & Cutting-Edge Technology

Founded by healthcare veterans in 1999, Pulmocare merges industry experience with pioneering technology for global health concerns.

Certified Efficiency

NABL-approved lab tests and ISO certifications back Occissor's 100% CFU reduction, endorsed by hospital testimonials for efficacy.

Enhanced Safety & Cost Efficiency

Pulmocare's solutions mean fewer HAIs, cleaner patient air, and cost-effective healthcare operations, enhancing patient care and efficiency.

Our Products

Occissor: Advanced Exhaled Air Sterilization

Pulmocare Occissor device utilises UV-based sterilisation to eliminate microorganisms from exhaled air in ventilators, ensuring a 100% reduction in CFU count. This innovative solution offers unparalleled safety without compromising airflow, pressure, or volume settings.

Know More About OCCISSOR

IAPS (Integrated Air Purification & Sterilisation)

Completely Purify & Sterilize the air inside the ICU, Operation Theater & Ambulance. Our IAPS systems can be used 24 x 7 – in presence of patients & staff continuously. Environment of ICU will remain sterilized always – reducing HAI

Know More About IAPS

Why Choose Pulmocare?

Benefits to Patients

Reduced Infection Risk

Patients are at a lower risk of acquiring infections, improving their overall safety and well-being.

Cleaner Air

Patients breathe in sterilised air, reducing the chances of airborne infections, especially in critical care units.

Comfortable Breathing

Minimal impact on airflow ensures a comfortable and safe breathing experience for ventilated patients.

Continuous Protection

IAPS operates 24/7 in the presence of patients, ensuring continuous air sterilization.

Portable and Convenient

The devices are portable and can be used in various healthcare settings, including ambulances, providing consistent protection to the patients during transit

Benefits to Hospitals

Reduced HAIs

Significant reduction in hospital-acquired infections leads to improved patient outcomes and reduced healthcare costs.

Non-Disruptive

Unlike traditional fumigation methods, IAPS can be used without evacuating patients or staff, minimizing disruptions in patient care.

Cost-Effective

These systems provide a cost-effective solution compared to disposable filters & other existing solutions available in the market, reducing the overall cost of the Hospitals.

Shock-Resistant

Durable and shock-resistant devices ensure long-term reliability in healthcare environments.

Remote Control

Remote functionality allows for easy monitoring and control, improving efficiency.

Improved Patient Care & Higher Revenues

By using IAPS & Occissor, 70% infection can be eliminated in ICU, which results in early discharge of patients and new patients can be admitted which will increase profitability & popularity of the hospitals.

Testimony for Occissor & IAPS

Certified Test Lab Reports

The performance report for the IAPS (Integrated Air Purifier System – ResQ Model) deployed in SGPGI’s Medical Genetics Lab has received highly favorable feedback.

SGPGI

Lucknow

RML given test lab report for pre occissor in which bacterial count was 30 CFU. Pre culture was showing growth of Stenotrophomonas maltophilia (20 CFU) & Enterococcus Casseliflavus (10 CFU). Post culture of sample, after incubation for 48 hours culture report was 100% sterilised

RML Laboratory

Lucknow

During a Laparoscopic Cholecystectomy surgery at Mayo Hospital in Lucknow, the OCCISSOR device was attached to the exhalation port of the anesthesia workstation. Samples were collected before and after the surgery. Microbial analysis revealed a significant reduction in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus presence in the exhaled gas, demonstrating OCCISSOR’s effectiveness in sterilizing the air during the procedure.

Mayo Hospital

Lucknow

Sahara Hospital used IAPS in their Ambulance & conducted microbial test for the same. After successful trial and analysing the test report, they given us results saying “IAPS with UV Sterilisation efficiently reduced the CFU count and percentage of Microbes by 99%